arrow
J

João Xavier de Araújo-Júnior

federal university of alagoas
H指数:28
被引数:2,395

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In Vitro and In Silico Evaluation of the Potentiating Effect of Thiadiazine Derivatives Against Multidrug-Resistant (MDR) Bacterial Strains

体外和计算机模拟评价噻二嗪衍生物对多药耐药(MDR)细菌菌株的增强作用

2026-08-160
OAAI
Microparticles of greenish-brown propolis extract: phytochemical, physicochemical characterisation and in vitro dissolution profile

绿色棕褐色蜂胶提取物的微颗粒:植物化学、物理化学表征及体外溶出曲线

2026-08-070
OA
Inhibitory effects of thiophene-2-thiazole hybrids against sensitive strains and resistant clinical isolates of Mycobacterium tuberculosis

噻吩-2-噻唑杂合体对结核分枝杆菌敏感菌株和耐药临床分离株的抑制作用

2026-05-030
OAAI
Modifying Antibiotic Activity of Synthetic Thiadiazine Analogs Against MDR Bacteria and ADMET Analysis
2025-10-010
OAAI
A case report about the detection of infectious hypodermal and hematopoietic necrosis virus (IHHNV) in shrimp displaying no clinical signs or histopathological lesions from farms on Colombia’s north coast

一份关于在哥伦比亚北部沿海养殖场的对虾中检测到无临床体征或组织病理学病变的传染性皮下及造血坏死病毒(IHHNV)的病例报告

2025-06-110
PRE
Evaluation of the Efflux Pump Inhibition Activity of Thiadiazine-Derived Compounds Against the Staphylococcus aureus 1199B Strain
2025-02-250
OAAI
Nanomolar activity of coumarin-3-thiosemicarbazones targeting Trypanosoma cruzi cruzain and the T. brucei cathepsin L-like protease

克氏锥虫和布氏组织蛋白酶L样蛋白酶靶向coumarin-3-thiosemicarbazones的纳摩尔活性

2025-02-010
PRE
Evaluating efflux pump inhibition in Staphylococcus aureus 1199B strain using thiadiazine-derived compounds: In vitro and in silico approaches

使用噻二嗪衍生的化合物评估金黄色葡萄球菌1199B菌株的外排泵抑制作用: 体外和计算机方法

2024-12-010
PRE
Thiazine-derived compounds in inhibiting efflux pump in Staphylococcus aureus K2068, mepA gene expression, and membrane permeability alteration

噻嗪衍生化合物抑制金黄色葡萄球菌K2068的外排泵,mepA基因表达和膜通透性改变

2024-10-010
OAAI
A consensus reverse docking approach for identification of a competitive inhibitor of acetyltransferase enhanced intracellular survival protein from Mycobacterium tuberculosis
2024-06-010
PRE
Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus
2023-10-017
PRE